Shruti Patel, MD

Assistant Professor of Medicine, Gastrointestinal oncology @stanfordmed & @vapaloalto |⚕️

[Shruti Patel, MD @ShrutiPatelMD]

Thrilled to share our latest in Journal of Clinical Oncology!

✨Comments & Controversies✨

We dive into the 'evidentiary gap' in @FDAOncology accelerated approvals—what happens when ‘fast-followers’ reach market without direct comparison?

https://t.co/GlNoHuavO6

@ChrisChenMD

[Shruti Patel, MD @ShrutiPatelMD]

Young-onset colorectal cancer deserves this kind of attention!

At @UCSFCancer inaugural Young Onset Colorectal Cancer Symposium today, with Dr. @KimmieNgMD delivering the keynote + chairs Drs. @KVanLoonMD and Chloe Atreya bringing people together to move research and care forward for these patients!

[Saeed Rafii, MD PhD FRCP @DrRafii_OncDoc]

Day 1 of our EOS Annual Conference wrapped up on a high note, surrounded by friends and colleagues @OncBrothers @SuyogCancer @ShrutiPatelMD @ProfSyedHussain.

Thank you all for your valuable insights and for making the day so enriching. Looking forward to Day 2! #EOS2026

[Shruti Patel, MD @ShrutiPatelMD]

The reality of the FDA approval is that the direct to consumer marketing will be even more aggressive. I did read all the nuance in your posts (which I ofc respect) but the grifter companies like function health are not using that nuance when marketing this and full body MRIs to their patients. (See this years Super Bowl ad for example)

You end by saying that “we should not be denying the test to people” except that this test is already not denied to people. People can pay out of pocket for this test currently.

I think the FDA saying this is safe makes sense but “efficacious” is wrong.

[Shruti Patel, MD @ShrutiPatelMD]

I think the one sided celebration comes from the fact that we are doctors AND humans.

All of us have taken care of patients who have missed an anniversary or maybe the birth of a grandkid. We know what extra time
(especially not on chemo) means for patients.

To say long term benefit seems unlikely therefore I’m not comfortable doesn’t seem fair in a disease that hasn’t had an advance in years.

[Shruti Patel, MD @ShrutiPatelMD]

@YJanjigianMD @myESMO Looking forward to seeing the data in person!!! Very exciting time for cancer vaccines!

[Shruti Patel, MD @ShrutiPatelMD]

@jryckman3 @OncBrothers Direct to consumer marketing is a heck of a strategy.

[Shruti Patel, MD @ShrutiPatelMD]

@TimothyJBrownMD @DanielGoycoMed @UTSWHemeOnc @utswcancer @littlejonesmd POST IT

[Shruti Patel, MD @ShrutiPatelMD]

@kerrihabsfan @ShrutiPateil Hi, this account was an imposter account and was selling this under my name. @x has finally taken action to ban the account after months of reporting this account as a fraud.

Will be monitoring for other accounts that might pop up but wanted to let you know!

[Steve Lee @steveleeyc]

Finally got our first #pancreaticcancer patient onto #daraxonrasib through @RevMedicines @FDAOncology Expanded Access Program. Turned into an unplanned bring-your-daughter-to-work day to get same-day consent to start therapy. Fingers crossed!

[Shruti Patel, MD @ShrutiPatelMD]

@drsmags CONGRATULATIONS!!!!!

[Dr Joseph McCollom DO @realbowtiedoc]

What an interrupting standing #ovation looks like from the front of #ASCO26 when a revolution in science comes for #pancsm treatment #GIonc.

[Shruti Patel, MD @ShrutiPatelMD]

An honor of a literal lifetime to discuss this trial for @ASCO #ScienceinSeconds

DOUBLE OVERALL SURVIVAL IN PANCREATIC CANCER 🤯

[ASCO @ASCO]

Major news from #ASCO26: A multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. “This is absolutely practice-changing” says @ShrutiPatelMD in this Science in Seconds. #pancan

Read the abstract: https://t.co/MbVCqGvYfz

[ASCO @ASCO]

Major news from #ASCO26: A multi-selective RAS(ON) inhibitor nearly doubles survival time in people with metastatic pancreatic cancer. “This is absolutely practice-changing” says @ShrutiPatelMD in this Science in Seconds. #pancan

Read the abstract: https://t.co/MbVCqGvYfz

[Dr. Cathy Eng @CathyEngMD]

So much fun last night! 🙏🏻 @OncBrothers for inviting us to discuss #GI updates #ASCO26. Followed by interviews from the next generation of 🤩 #oncologists. @rachnatshroff @GIcancerDoc @CJMcCollum @BernabeCarolina #ShrutiPatel. Had to make fun of my BFF @GIcancerDoc 😂

[Shruti Patel, MD @ShrutiPatelMD]

@rachnatshroff @ASCOPres @ASCO @jrgralow @ErikaHamilton9 @montypal Considering I had to take 3 lbs out of my check-in bag at the airport counter 😳, I would second this plenary nomination 🙏🏽

[Shruti Patel, MD @ShrutiPatelMD]

Another year, another red eye to #ASCO26

Busy thursday clinic ✅
Frantic last minute packing ✅
@LouSeal01 blanket ✅

See yall soon!!!

[Allison Rosen, MS @ARosen380]

Happy National Doctor’s Day to some of the most amazing doctors. I know that work in oncology and help save lives every day like mine.

#DoctorsDay #GITwitter #CRCSM

@ShrutiPatelMD @skopetz @milenasuarez @drholowatyj @realbowtiedoc @VanMorrisMD @KimmieNgMD @NancyYouMD

[Shruti Patel, MD @ShrutiPatelMD]

@ARosen380 @skopetz @milenasuarez @drholowatyj @realbowtiedoc @VanMorrisMD @KimmieNgMD @NancyYouMD @drfolamay @ppisters @ryanhuey @UTMDAnderson @BCMCancerCenter @ASCO @DanaFarber 💕💕💕 I am a better doctor because I know you!!! Thank YOU!!!

[Oncology Brothers @OncBrothers]

15-30% of GEA/Gastric Adenocaecinoma is Her2+! Here with @SunnieSKim and @Sam_Cytryn we discuss the current landscape of Her2 metastatic disease and recent data around HERIZON-GEA-01!

Full 🗣️
⭐️ OncBrothers and @gotoPER website
⭐️ “Oncology Brothers” podcast

#gism #OncTwitter